Thermo Fisher Scientific Inc.
TMO
$459.30
$6.701.48%
NYSE
| 03/28/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.91% | 9.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.91% | 9.83% | |||
| Cost of Revenue | -8.51% | 9.83% | |||
| Gross Profit | -11.90% | 9.82% | |||
| SG&A Expenses | -4.43% | 6.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 100.74% | -- | |||
| Total Operating Expenses | -6.16% | 7.25% | |||
| Operating Income | -23.86% | 20.62% | |||
| Income Before Tax | -18.70% | 16.14% | |||
| Income Tax Expenses | -54.25% | -26.09% | |||
| Earnings from Continuing Operations | -15.94% | 21.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 16.67% | -20.00% | |||
| Net Income | -15.94% | 21.53% | |||
| EBIT | -23.86% | 20.62% | |||
| EBITDA | -18.44% | 17.73% | |||
| EPS Basic | -15.03% | 22.18% | |||
| Normalized Basic EPS | -24.08% | 20.68% | |||
| EPS Diluted | -15.19% | 22.33% | |||
| Normalized Diluted EPS | -24.08% | 20.36% | |||
| Average Basic Shares Outstanding | -1.06% | -0.53% | |||
| Average Diluted Shares Outstanding | -1.06% | -0.26% | |||
| Dividend Per Share | 9.30% | 0.00% | |||
| Payout Ratio | 0.19% | -0.18% | |||